ambroxol has been researched along with Pneumonia, Viral in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takano, H | 1 |
1 other study available for ambroxol and Pneumonia, Viral
| Article | Year |
|---|---|
Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
Topics: Ambroxol; Angiotensin-Converting Enzyme 2; Bromhexine; Clinical Trials as Topic; COVID-19; COVID-19 | 2020 |